Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2026 is 0.00% vs 0.00% in Jun 2025
Consolidate Net Profit
YoY Growth in quarter ended Jun 2026 is 11.36% vs 16.23% in Jun 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2026 is 6.85% vs 20.58% in Jun 2025
Interest
YoY Growth in quarter ended Jun 2026 is 144.74% vs 0.00% in Jun 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025
Compare Quarterly Results Of Xspray Pharma AB With
Quarterly - Net Sales
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is -7.57% vs 21.78% in Dec 2025
YoY Growth in quarter ended Jun 2026 is 11.36% vs 16.23% in Jun 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2026 is -17.23% vs 24.94% in Dec 2025
YoY Growth in quarter ended Jun 2026 is 6.85% vs 20.58% in Jun 2025
Quarterly - Interest
QoQ Growth in quarter ended Jun 2026 is 116.28% vs -14.00% in Dec 2025
YoY Growth in quarter ended Jun 2026 is 144.74% vs 0.00% in Jun 2025






